Peer Review History
| Original SubmissionApril 16, 2025 |
|---|
|
-->PONE-D-25-19278-->-->Pooled prevalence and Multimorbidity of diarrhea and wasting and its associated factors among children aged 6-24 months in East Africa: Insight from Recent Demographic Health Survey: A Multilevel analysis-->-->PLOS One Dear Dr. Melesse, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Feb 04 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:-->
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Edison Arwanire Mworozi, M.D Academic Editor PLOS One Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please amend either the abstract on the online submission form (via Edit Submission) or the abstract in the manuscript so that they are identical. 3. Please upload a new copy of Figure 1 as the detail is not clear. Please follow the link for more information: https://journals.plos.org/plosone/s/figures 4. Please include your tables as part of your main manuscript and remove the individual files. Please note that supplementary tables (should remain/ be uploaded) as separate "supporting information" files. 5. We note that there is identifying data in the Supporting Information file < Table 1_DW.docx >. Due to the inclusion of these potentially identifying data, we have removed this file from your file inventory. Prior to sharing human research participant data, authors should consult with an ethics committee to ensure data are shared in accordance with participant consent and all applicable local laws. Data sharing should never compromise participant privacy. It is therefore not appropriate to publicly share personally identifiable data on human research participants. The following are examples of data that should not be shared: -Name, initials, physical address -Ages more specific than whole numbers -Internet protocol (IP) address -Specific dates (birth dates, death dates, examination dates, etc.) -Contact information such as phone number or email address -Location data -ID numbers that seem specific (long numbers, include initials, titled “Hospital ID”) rather than random (small numbers in numerical order) Data that are not directly identifying may also be inappropriate to share, as in combination they can become identifying. For example, data collected from a small group of participants, vulnerable populations, or private groups should not be shared if they involve indirect identifiers (such as sex, ethnicity, location, etc.) that may risk the identification of study participants. Additional guidance on preparing raw data for publication can be found in our Data Policy (https://journals.plos.org/plosone/s/data-availability#loc-human-research-participant-data-and-other-sensitive-data) and in the following article: http://www.bmj.com/content/340/bmj.c181.long. Please remove or anonymize all personal information, ensure that the data shared are in accordance with participant consent, and re-upload a fully anonymized data set. Please note that spreadsheet columns with personal information must be removed and not hidden as all hidden columns will appear in the published file. 6. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information . 7. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Additional Editor Comments: Please read and comprehend the comments made by the reviewers then revise accordingly. Have a great week. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions -->Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. --> Reviewer #1: Partly Reviewer #2: Yes ********** -->2. Has the statistical analysis been performed appropriately and rigorously? --> Reviewer #1: No Reviewer #2: Yes ********** -->3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.--> Reviewer #1: Yes Reviewer #2: Yes ********** -->4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.--> Reviewer #1: No Reviewer #2: Yes ********** -->5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)--> Reviewer #1: This manuscript addresses an important and timely topic by analyzing the diarrhea and wasting among young children in East Africa using Demographic and Health Survey (DHS) data. The authors aim to estimate the pooled prevalence of this co-occurrence and identify associated factors through multilevel analysis. While the study’s focus is relevant for public health and nutrition policy in low-income settings, several conceptual, methodological, and reporting issues reduce the clarity, coherence, and scientific rigor of the manuscript. The following comments aim to provide constructive suggestions for improving the theoretical framing, variable and model explanation, and interpretation of results. Introduction Definition of multimorbidity The central conceptual framework of the manuscript is problematic. The authors repeatedly frame the co-occurrence of diarrhea and wasting as a form of “multimorbidity.” However, this interpretation does not align with standard definitions in the literature, which describe multimorbidity as the co-existence of multiple chronic conditions within the same individual, typically requiring long-term care or management. Diarrhea, as it is defined a in this study, reflects an acute condition in children. Wasting is referred to as "acute malnutrition", implying a condition with clear short-term or recent onset. However, later in the text, wasting is defined as "a weight-for-height ratio more than two standard deviations below the mean for the reference population", which does not convey any temporal dimension and creates a conceptual inconsistency. Change the study as an investigation of co-occurring entities or syndemic vulnerabilities would be conceptually more accurate and scientifically defensible. the use of “multimorbidity” is misleading and weakens the study’s coherence. Also, the manuscript lacks consistency in the use of terminology when referring to the co-occurrence of diarrhea and wasting. The authors use multiple labels—“DW,” “DWM,” “DW multimorbidity,” “diarrhea and wasting multimorbidity”— and this leads to confusion about whether “DW” is meant to represent: a descriptive epidemiological finding (as the co-occurrence of two distinct conditions), a new conceptualized clinical entity, a binary variable in the statistical model, or a form of “multimorbidity” in the traditional sense (which would be incorrect, as previously noted). First, the manuscript should explain if DW is treated as a clinical concept, an analytic outcome, or both. Also, it should define how “DW” is constructed as a variable, using a consistent acronym and label. Methods Inclusion and exclusion criteria The manuscript fails to report the inclusion and exclusion criteria used in the final analytic sample of 78,962 children. It is unclear if children without anthropometric measurements or recent diarrhea data were excluded, if implausible anthropometric values were removed, if the sample includes all children in the age range or only those with complete data… It is recommended that the authors provide a transparent flow of case inclusion (preferably as a diagram), explicitly defining all exclusion criteria and justify the final sample size in the context of the original population. In line with this, the manuscript provides no information on how missing data were handled, either for the primary outcome (DW) or for covariates. This is an important omission. The authors should quantify the proportion of missing data for each variable used, explain the strategy chosen to manage missing values and justify the approach. Selected variables Although the manuscript explains the derivation of some constructed variables (media exposure, birth weight), it remains unclear how other independent variables were operationalized. The authors should explicitly state if these variables were used in their original DHS format or additional recoding was applied. Analytic approach The afirmation “this structure could violate the assumptions of independence of observations and equal variance inherent in traditional logistic regression models” is conceptually confused and is not a valid justification for the choice of multilevel modeling, since concerns regarding independence and variance assumptions are already addressed through the survey design correction applied via the svy commands. The authors employed a multilevel mixed-effects binary logistic regression model to estimate the association between child-level and community-level factors and the likelihood of co-occurring diarrhea and wasting (“DW”). Multilevel modeling should be justified based on theoretical grounds and the need to model between-cluster variability explicitly. this choice could be appropriate given the aim of the study and the hierarchical nature of DHS data. Results The results section presents some weaknesses in reporting, interpretation and clarity. Table 1 presents several issues that limit its clarity and interpretability. First, the total number of children included in the analysis is not reported, which is essential to contextualize the percentages. Some units of measurement for variables are not clearly indicated. Additionally, for dichotomous variables, it would improve readability to report only one category to avoid redundancy (“Child sex”,”Mother ocupation”…). It would be helpful to report the prevalence of diarrhea and malnutrition separately, in addition to the joint outcome (DW), as this would offer greater epidemiological context and comparability with prior studies. The interpretation of the MOR could be clarified. First, the use of the term "significant variation" could be misinterpreted in a statistical sense. To avoid ambiguity, it would be clearer to use terms such as "substantial" or "considerable" variation when interpreting the MOR. The MOR does not compare children in areas of "high vs. low prevalence", but rather quantifies the median increase in odds when comparing two children with identical characteristics from two randomly selected countries. A MOR of 2.39 reflects substantial between-country heterogeneity. A decrease in the MOR from the null model to Model III actually indicates that the model explains more, not less, of the between-cluster variability in the outcome. The AOR for rural residence of 0.85 is inaccurately described as a 20% reduction, when it actually represents a 15% lower odds of DW. Also, there appears to be a formatting or numerical error in the reporting of the adjusted odds ratio for “Secondary” in mother education status: the AOR is reported as 1.46, but the 95% confidence interval is 1.49–3.03, which is inconsistent. The use of a forest plot typically implies that independent estimates ( from different studies or settings) are being synthesized, often using meta-analytic methods. That is clearly not the case here.The plot assigns equal weights (9.1%) to each country, despite substantial differences in sample sizes and it is not well explained what the plotted values reflect. If the intention was to display variation in prevalence across countries, alternative formats such as geographical maps would be more appropriate and transparent. At a minimum, the figure should be accompanied by a clear methodological explanation. Discussion Some changes are needed to improve the clarity of the discussion.The beginning of the discussion repeat the study aim and results with little interpretive value. The authors report a weighted pooled prevalence of diarrhea and wasting multimorbidity (DW) of 9% among children aged 6–24 months in East Africa and cite references 22 and 23 to support the significance of this burden. However, upon closer examination, these references pertain to studies on breastfeeding practices , not to the prevalence of diarrhea, wasting, or their co-occurrence. This makes them inappropriate citations in this context. Additionally, while references 16 and 31 (Demissie et al., 2021; Tareke et al., 2022) do report on the prevalence of diarrhea alone in sub-Saharan and East African children (approximately 14–16%), they do not assess the joint occurrence of diarrhea and wasting. These sources cannot be used to validate or compare the DW prevalence reported in the current study. The finding that younger maternal age (15–24 and 25–34 years) is associated with significantly lower odds of DW compared to older mothers (35–49 years) appears counterintuitive, especially considering previous literature suggesting that young maternal age is a risk factor for child undernutrition and illness (e.g., refs 16, 29). However, this result may be influenced by several underlying factors that are not adequately explored in the discussion. It would strengthen the study to explore whether the effect of maternal age persists when stratifying by key mediating factors (maternal education, household wealth, access to care...) It also happens with the association between rural residence and lower DW risk. It contradicts many prior studies. The proposed explanation (“more extended breastfeeding and community support”) is not enough substantiated with evidence. While the study provides valuable insights, it may be worth reconsidering the selection and operationalization of some key variables. For instance, breastfeeding is only captured through the timing of initiation within the first hour of birth. As i know, DHS offers additional indicators such as exclusive breastfeeding duration, continued breastfeeding at 1 and 2 years, etc. which are strongly associated with both diarrhea and malnutrition. Differences between countries (Malawi and Zimbabwe) are just mentioned .The authors selected a multilevel modeling approach that includes country but this choice is not matched by a sufficiently robust analytical or interpretative emphasis on country-level differences. There is no enough consideration of potential macro-level determinants such as differences in health system infrastructure, national nutrition or vaccination programs, water and sanitation policies, or socioeconomic indicators. The authors could include a brief summary of key contextual differences between countries with notably high/low DW prevalence and discuss possible structural or policy-level explanations for these differences (using DHS data or relevant literature). Grammatical, typographical, and syntactic errors The manuscript contains grammatical, typographical, and syntactic errors. for example: “This studyis based...” “Children who were breastfeed...” “among children age from 6–24months” “included in to multivariable analysis”. Also, some variable labels are misspelled: “laterine” , “Media accesses” , “birth weight small”… These errors hinder readability. A language revision by an english speaker or professional editor with experience in academic writing is recommended. General conclusions The main issue with this article lies in its conceptual framework, which is fundamentally flawed. The outcome variable combines an acute infectious disease (diarrhea) with a non-acute condition (wasting) under the label of multimorbidity. This does not align with standard definitions of multimorbidity in the literature and undermines the theoretical coherence of the study. The use of multilevel modeling is, in principle, an appropriate analytic strategy. However, if the model is designed to account for between-country variability, the manuscript should include a substantial section that compares and interprets the results across countries with detail. This aspect is largely underdeveloped. The article also fails to describe how missing data were handled or what inclusion and exclusion criteria were applied in the final analytic sample. In addition, the manuscript contains several minor issues—including grammatical and typographical errors, inconsistencies in variable labeling, and occasional formatting problems in tables. Moreover, the presentation of the results is suboptimal, with incomplete descriptive statistics, unclear figure and insufficient explanation of key tables and variables. these issues are relatively easy to correct , they remain secondary to the more fundamental concerns regarding the study’s conceptual framework and outcome definition. Reviewer #2: There is need to be consistent with abbreviations, DW is used sometimes and DVM is used some other time.; line 36 and line 48 So many Typos and formatting errors that needs to be corrected: Line 96; ‘Photogenes’ Do you mean pathogens? Line 106 Severe not sever Method: Data source :‘This study is based on most recent DHS conducted after 2016 appears vague, specify exact survey years for each country to improve transparency. Line 142: DHS definition of diarrhea (two-week recall) may introduce recall bias; please acknowledge this limitation. ********** -->6. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .--> Reviewer #1: Yes: Alicia Serrano de la Cruz Reviewer #2: Yes: Elizabeth Adedire ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. |
| Revision 1 |
|
<p>Pooled prevalence and co-occurrence of diarrhea and wasting and its associated factors among children aged 6-24 months in East Africa: Insight from Recent Demographic Health Survey: A Multilevel analysis PONE-D-25-19278R1 Dear all, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Edison Arwanire Mworozi, M.D Academic Editor PLOS One Language and Formatting: Despite proofreading, some minor typographical errors and formatting inconsistencies remain (e.g., "studyis" and "laterine"). Abstract Length: The abstract is slightly lengthy and could be more concise to align with journal standards. Repetition in Discussion: While the authors addressed the repetitive opening, some parts of the discussion still reiterate findings without adding interpretive value. Clarity in Results: Some sections of the results could be streamlined for better readability, especially when discussing statistical measures. |
| Formally Accepted |
|
PONE-D-25-19278R1 PLOS One Dear Dr. Melesse, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Professor Edison Arwanire Mworozi Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .